Skip to main content
. 2024 Jan 18;25(2):1173. doi: 10.3390/ijms25021173

Table 6.

Number of participants classified as plasmatic Aβ+ or plasmatic Aβ− based on the plasma soluble Aβ42/Aβ40 ratio, using a threshold of 0.0465, as determined by decision tree, and according to their amyloid status determined by CSF or PET analysis.

All Individuals CSF/PET Aβ+ CSF/PET Aβ−
Plasmatic Aβ+ 64 32
Plasmatic Aβ− 10 45